+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Medicine Market by Product, Application, End Users - Global Forecast 2025-2030- Product Image
Personalized Medicine Market by Product, Application, End Users - Global Forecast 2025-2030- Product Image
Sale

Personalized Medicine Market by Product, Application, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977907
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Personalized Medicine Market grew from USD 542.10 billion in 2023 to USD 575.50 billion in 2024. It is expected to continue growing at a CAGR of 6.67%, reaching USD 852.02 billion by 2030.

Personalized medicine refers to an innovative approach in the medical field that tailors treatment and healthcare decisions to the individual characteristics of each patient, including genetic, environmental, and lifestyle factors. Its necessity arises from the increasing awareness that traditional one-size-fits-all solutions may not be effective for everyone due to human genetic variability. Personalized medicine finds application in areas such as oncology, where treatments can be customized based on a patient's genetic profile, and in other diseases like cardiovascular diseases, diabetes, and rare genetic disorders. The end-use scope extends from individual patients to broader healthcare systems that aim for more effective and efficient patient care. Market insights reveal key factors influencing growth include technological advancements in genomics, increasing R&D expenditure, and a growing prevalence of chronic diseases. The rise of artificial intelligence and machine learning in biotechnology also presents opportunities for enhanced diagnostic and predictive analytics. However, challenges such as high costs associated with personalized treatments, regulatory hurdles, and ethical considerations around genetic data privacy constrain market expansion. Additionally, there is a need for more extensive clinical trials and more comprehensive patient databases to validate and bolster confidence in personalized approaches. Innovation and research should focus on areas like advanced biomarker discovery, improved genome sequencing technologies, and more integrated healthcare IT solutions to streamline data management and analyses. Continuous collaboration amongst pharmaceutical companies, tech firms, and healthcare providers will be crucial in driving innovation. The market's dynamic nature, driven by rapid technological advances, denotes the potential for substantial growth, especially within emerging economies where healthcare infrastructure is evolving. Businesses should keep an eye on regulatory developments and strategically invest in data analytics and patient engagement platforms to leverage personalized medicine’s growth opportunities effectively.

Understanding Market Dynamics in the Personalized Medicine Market

The Personalized Medicine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in biotechnology research initiatives and improved understanding of genetics
    • Surge in the adoption of personalized treatment strategies for targeting complex diseases
    • Supportive government initiatives to raise awareness for and access to personalized medicine
  • Market Restraints
    • Complexities in the implementation of personalized medicine and lack of skilled personnel
  • Market Opportunities
    • Ongoing R&D activities for improvements in personalized medicines
    • Potential for the adoption of virtual and digital strategies for personalized medicine
  • Market Challenges
    • Limited accessibility and issues related to accuracy

Exploring Porter’s Five Forces for the Personalized Medicine Market

Porter’s Five Forces framework further strengthens the insights of the Personalized Medicine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Personalized Medicine Market

External macro-environmental factors deeply influence the performance of the Personalized Medicine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Personalized Medicine Market

The Personalized Medicine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Personalized Medicine Market

The Personalized Medicine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Personalized Medicine Market

The Personalized Medicine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Personalized Medical Care
      • Health Information Technology
      • Telemedicine
    • Personalized Medicine Diagnostics
      • Direct-to-consumer (DTC) Diagnostics
      • Esoteric Lab Services
      • Esoteric Lab Tests
      • Genetic Testing
    • Personalized Medicine Therapeutics
      • Genomic Medicine
      • Medical Devices
      • Pharmaceutical
    • Personalized Nutrition & Wellness
      • Complementary & Alternative Medicine
      • Retail Nutrition
  • Application
    • Antiviral
    • Cardiology
    • Immunology
    • Neurology
    • Oncology
    • Psychiatry
  • End Users
    • Academic Research Institutes & Research Laboratories
    • Bio & Health Informatics Companies
    • Contract Research Organizations
    • Diagnostic Companies & Testing Facilities
    • Hospitals & Clinical Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
5.1.2. Restraints
5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
5.1.3. Opportunities
5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
5.1.4. Challenges
5.1.4.1. Limited accessibility and issues related to accuracy
5.2. Market Segmentation Analysis
5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Personalized Medicine Market, by Product
6.1. Introduction
6.2. Personalized Medical Care
6.2.1. Health Information Technology
6.2.2. Telemedicine
6.3. Personalized Medicine Diagnostics
6.3.1. Direct-to-consumer (DTC) Diagnostics
6.3.2. Esoteric Lab Services
6.3.3. Esoteric Lab Tests
6.3.4. Genetic Testing
6.4. Personalized Medicine Therapeutics
6.4.1. Genomic Medicine
6.4.2. Medical Devices
6.4.3. Pharmaceutical
6.5. Personalized Nutrition & Wellness
6.5.1. Complementary & Alternative Medicine
6.5.2. Retail Nutrition
7. Personalized Medicine Market, by Application
7.1. Introduction
7.2. Antiviral
7.3. Cardiology
7.4. Immunology
7.5. Neurology
7.6. Oncology
7.7. Psychiatry
8. Personalized Medicine Market, by End Users
8.1. Introduction
8.2. Academic Research Institutes & Research Laboratories
8.3. Bio & Health Informatics Companies
8.4. Contract Research Organizations
8.5. Diagnostic Companies & Testing Facilities
8.6. Hospitals & Clinical Care
9. Americas Personalized Medicine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Personalized Medicine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Personalized Medicine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 62. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 64. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 65. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 66. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 67. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 99. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 101. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 103. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 104. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 106. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 108. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 110. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 111. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 122. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 123. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 124. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 125. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 164. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 165. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 166. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 167. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 184. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 187. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 194. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 202. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 203. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 226. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 228. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 229. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 230. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 231. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 251. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 252. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 254. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 256. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 258. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 259. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 261. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 263. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 264. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 265. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 266. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONAL

Companies Mentioned

The leading players in the Personalized Medicine market, which are profiled in this report, include:
  • Abbott Laboratories
  • Amgen, Inc.
  • AstraZeneca
  • Bayer Ag
  • BIOGEN INC.
  • Eli Lilly and Company
  • Exact Sciences Corporation
  • Exagen Inc
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • Glaxosmithkline Plc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Precision Biologics, Inc.
  • QIAGEN GmbH
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 575.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 852.02 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Personalized Medicine Market Size, Share & Trends Analysis Report by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Personalized Medicine Market Size, Share & Trends Analysis Report by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Hyper Personalized Medicine Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product, Application, End-User, Region, By Country: 2020-2030 - Product Image

Hyper Personalized Medicine Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product, Application, End-User, Region, By Country: 2020-2030

  • Report
  • 311 Pages
  • Global
From
Personalized Medicines - Global Strategic Business Report - Product Image

Personalized Medicines - Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Clinical, Preclinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Clinical, Preclinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Personalized Medicine Global Market Report 2024 - Product Image

Personalized Medicine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Personalized Medicine Market

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.